HSBC Holdings
VAXX

HSBC Holdings’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

HSBC Holdings’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,301
Closed -$8.83K – 3230
2024
Q1 		$8.83K Buy
+12,301
New +$8.92K ﹤0.01% 3017

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

HSBC Holdings's VAXX Position: Q2 2024 in Review

HSBC Holdings sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 12,301 shares — an estimated $8.83K sold.

HSBC Holdings first reported a position in VAXX in Q1 2024 and held it in 1 quarter. The position peaked at $8.83K in Q1 2024. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • HSBC Holdings reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • HSBC Holdings sold 12,301 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $8.83K.
  • HSBC Holdings first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2024 and held it in 1 quarter.
  • HSBC Holdings's Vaxxinity, Inc. Class A Common Stock position peaked at $8.83K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on HSBC Holdings's 13F filing for Q2 2024, filed 12 Aug 2024.